Download PDF
Am J Perinatol
DOI: 10.1055/a-1925-1659
Original Article

Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence

Deepika Sankaran 
1   Division of Neonatology, Department of Pediatrics, University at Buffalo, Buffalo, New York
2   Division of Neonatology, Department of Pediatrics, University of California at Davis, Sacramento, California
,
Shikha Rawat
3   Department of Economics, Stony Brook University, Stony Brook, New York
4   Research Analyst, American Express, New York, New York
,
Jennifer L. Kachelmeyer 
1   Division of Neonatology, Department of Pediatrics, University at Buffalo, Buffalo, New York
,
Emily S. Li
1   Division of Neonatology, Department of Pediatrics, University at Buffalo, Buffalo, New York
,
Anne M. Reynolds
1   Division of Neonatology, Department of Pediatrics, University at Buffalo, Buffalo, New York
,
Munmun Rawat
1   Division of Neonatology, Department of Pediatrics, University at Buffalo, Buffalo, New York
,
Praveen Chandrasekharan
1   Division of Neonatology, Department of Pediatrics, University at Buffalo, Buffalo, New York
› Author Affiliations Funding P.C. was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; grant number: R01HD104909/R03HD096510) and the National Institutes of Health (NIH)/National Heart Lung and Blood Institute (NHLBI; grant no.: K12 HL138052), and research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. D.S. was supported by Children's Miracle Network at UC Davis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding agencies had no role in the design of this manuscript.
› Further Information
    Permissions and Reprints

Abstract

Objectives Our objective was to evaluate the trend and to assess the impact of maternal region of residence in Western New York (WNY), on severe neonatal opioid withdrawal syndrome (NOWS).

Study Design Term infants' born at gestational age greater than or equal to 37 weeks with severe NOWS, defined as withdrawal resulting in the receipt of pharmacologic therapy from WNY admitted to our neonatal intensive care unit (NICU) from January 1, 2008 to December 31, 2016, were included. Severe NOWS admissions to our NICU from the following five regions were controlled with birth and insurance data: (1) Urban North, (2) Erie Coastal, (3) Niagara Frontier, (4) Southern Tier, and (5) Urban South.

Results “Urban South” residence was associated with an increased risk of severe NOWS (adjusted odds ratio = 1.8, 97.5% confidence interval: 1.1–2.9). The trend in admission for severe NOWS doubled between 2008 to 2010 and 2014 to 2016 (p = 0.01). More infants born to maternal nonprescribed opioid users were placed in foster care at discharge (36.5 vs. 1.9%, p < 0.001).

Conclusion In WNY, neonates born to mothers from the “Urban South” were twice at risk of being admitted for severe NOWS. One-third of infants with severe NOWS after nonprescribed opioid use were placed in foster care. Implementing targeted strategies at the community level may help improve outcomes in NOWS.

Key Points

  • Maternal region of residence is a risk factor for severe neonatal opioid withdrawal.

  • Admissions for severe neonatal opioid withdrawal trended up from 2008 to 2010 to 2014 to 2016.

  • One-third of the infants born to mothers on nonprescribed opioids were discharged to foster care.

Keywords

severe neonatal opioid withdrawal syndrome - region of residence - neonatal intensive care unit - trends in severe NOWS

Note

The data were previously presented as a poster in Pediatric Academic Societies meeting and in the Eastern Society of Pediatrics Research meeting in 2019.


Authors' Contributions

D.S., S.R., J.L.K., E.S.L., A.M.R., M.R., and P.C. made substantial contributions to conception, design, and drafting of the manuscript. All the authors have critically revised and approved the final version of the manuscript. All authors agree to be accountable for all aspects of the work.


Supplementary Material



Publication History

Received: 30 January 2022

Accepted: 01 August 2022

Accepted Manuscript online:
16 August 2022

Article published online:
31 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Wen LS, Warren KE. Combatting the opioid epidemic: Baltimore's experience and lessons learned. J Public Health (Oxf) 2018; 40 (02) e107-e111
    CrossrefPubMedGoogle Scholar
  • 2 Gomes T, Khuu W, Martins D. et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. BMJ 2018; 362: k3207
    CrossrefPubMedGoogle Scholar
  • 3 Villapiano NLG, Winkelman TNA, Kozhimannil KB, Davis MM, Patrick SW. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatr 2017; 171 (02) 194-196
    CrossrefPubMedGoogle Scholar
  • 4 Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18) 1934-1940
    CrossrefPubMedGoogle Scholar
  • 5 Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999-2014. MMWR Morb Mortal Wkly Rep 2018; 67 (31) 845-849
    CrossrefPubMedGoogle Scholar
  • 6 Patrick SW, Barfield WD, Poindexter BB. Committee on Fetus and Newborn, Committee on Substance Use and Prevention. Neonatal opioid withdrawal syndrome. Pediatrics 2020; 146 (05) e2020029074
    CrossrefPubMedGoogle Scholar
  • 7 Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015; 372 (16) 1573-1574
    PubMedGoogle Scholar
  • 8 Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths–United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2016; 64 (50-51): 1378-1382
    CrossrefPubMedGoogle Scholar
  • 9 Hudak ML, Tan RC. COMMITTEE ON DRUGS, COMMITTEE ON FETUS AND NEWBORN, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129 (02) e540-e560
    CrossrefPubMedGoogle Scholar
  • 10 Milliren CE, Gupta M, Graham DA, Melvin P, Jorina M, Ozonoff A. Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hosp Pediatr 2018; 8 (01) 15-20
    CrossrefPubMedGoogle Scholar
  • 11 Strahan AE, Guy Jr GP, Bohm M, Frey M, Ko JY. Neonatal abstinence syndrome incidence and health care costs in the United States, 2016. JAMA Pediatr 2020; 174 (02) 200-202
    CrossrefPubMedGoogle Scholar
  • 12 Goedel WC, Marshall BDL, Spangler KR. et al. Increased risk of opioid overdose death following cold weather: a case-crossover study. Epidemiology 2019; 30 (05) 637-641
    CrossrefPubMedGoogle Scholar
  • 13 New York State County/ZIP Code Perinatal Data Profile. Accessed August 23, 2022, at: https://www.health.ny.gov/statistics/chac/perinatal/
    PubMedGoogle Scholar
  • 14 Vermette SJ. Proceedings of the Rochester Academy of Science. https://cdm16694.contentdm.oclc.org/digital/collection/p16694coll84/id/6829
    PubMedGoogle Scholar
  • 15 U.S. Census. QuickFacts. Buffalo city, New York. Accessed August 23, 2022 at: https://www.census.gov/quickfacts/fact/table/buffalocitynewyork
    PubMedGoogle Scholar
  • 16 Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open 2018; 1 (02) e180217-e180217
    CrossrefPubMedGoogle Scholar
  • 17 Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017. JAMA 2021; 325 (02) 146-155
    CrossrefPubMedGoogle Scholar
  • 18 Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 2016; 315 (15) 1624-1645
    CrossrefPubMedGoogle Scholar
  • 19 HHS GOV-opioid epidemic. Accessed August 23, 2022 at: https://www.hhs.gov/opioids/about-the-epidemic/index.html
    PubMedGoogle Scholar
  • 20 Honein MA, Boyle C, Redfield RR. Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics 2019; 143 (03) e20183801
    CrossrefPubMedGoogle Scholar
  • 21 Meisenberg BR, Grover J, Campbell C, Korpon D. Assessment of opioid prescribing practices before and after implementation of a health system intervention to reduce opioid overprescribing. JAMA Netw Open 2018; 1 (05) e182908-e182908
    CrossrefPubMedGoogle Scholar
  • 22 Mark J, Argentieri DM, Gutierrez CA. et al. Ultrarestrictive opioid prescription protocol for pain management after gynecologic and abdominal surgery. JAMA Netw Open 2018; 1 (08) e185452-e185452
    CrossrefPubMedGoogle Scholar
  • 23 Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol 2015; 35 (08) 650-655
    CrossrefPubMedGoogle Scholar
  • 24 Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome—28 States, 1999-2013. MMWR Morb Mortal Wkly Rep 2016; 65 (31) 799-802
    CrossrefPubMedGoogle Scholar
  • 25 Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open 2019; 2 (06) e196373-e196373
    CrossrefPubMedGoogle Scholar
  • 26 Kiang MV, Basu S, Chen J, Alexander MJ. Assessment of changes in the geographical distribution of opioid-related mortality across the United States by opioid type, 1999-2016. JAMA Netw Open 2019; 2 (02) e190040-e190040
    CrossrefPubMedGoogle Scholar
  • 27 Patrick SW, Faherty LJ, Dick AW, Scott TA, Dudley J, Stein BD. Association among county-level economic factors, clinician supply, metropolitan or rural location, and neonatal abstinence syndrome. JAMA 2019; 321 (04) 385-393
    CrossrefPubMedGoogle Scholar
  • 28 Guy Jr GP, Zhang K, Bohm MK. et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017; 66 (26) 697-704
    CrossrefPubMedGoogle Scholar
  • 29 Buffalo demographics-census. E-pub 2014. Accessed August 23, 2022, at: https://www.census.gov/quickfacts/fact/table/buffalocitynewyork/PST045221
    PubMedGoogle Scholar
  • 30 Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008; 299 (01) 70-78
    CrossrefPubMedGoogle Scholar
  • 31 Peeler M, Gupta M, Melvin P. et al. Racial and ethnic disparities in maternal and infant outcomes among opioid-exposed mother-infant dyads in Massachusetts (2017-2019). Am J Public Health 2020; 110 (12) 1828-1836
    CrossrefPubMedGoogle Scholar
  • 32 SAMHSA. 2016 . Accessed August 23, 2022, at: https://www.samhsa.gov/programs
    PubMed
  • 33 Loch SF, Stein BD, Ghertner R. et al. Neonatal opioid withdrawal syndrome is associated with infant foster care entry at the county level. Health Aff (Millwood) 2021; 40 (11) 1776-1783
    CrossrefPubMedGoogle Scholar
  • 34 Waite D, Greiner MV, Laris Z. American Academy of Pediatrics Council on Foster Care A, and Kinship Care. Putting families first: how the opioid epidemic is affecting children and families, and the child welfare policy options to address it. J Appl Res Child: Inform Policyr Child Risk 2018; 9 (01) Article 4 . Accessed August 23, 2022, at: https://digitalcommons.library.tmc.edu/childrenatrisk/vol9/iss1/4
    PubMedGoogle Scholar
  • 35 Wade M, Fox NA, Zeanah CH, Nelson CA. Effect of foster care intervention on trajectories of general and specific psychopathology among children with histories of institutional rearing: a randomized clinical trial. JAMA Psychiatry 2018; 75 (11) 1137-1145
    CrossrefPubMedGoogle Scholar
  • 36 Windsor J, Benigno JP, Wing CA. et al. Effect of foster care on young children's language learning. Child Dev 2011; 82 (04) 1040-1046
    CrossrefPubMedGoogle Scholar
  • 37 McGowan EC, Laptook AR, Lowe J. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Developmental outcomes of extremely preterm infants with a need for child protective services supervision. J Pediatr 2019; 215: 41-49.e4
    CrossrefPubMedGoogle Scholar
  • 38 Doyle Jr. JJ. Child protection and adult crime: using investigator assignment to estimate causal effects of foster care. J Polit Econ 2008; 116 (04) 746-770
    CrossrefPubMedGoogle Scholar
  • 39 Fill MA, Miller AM, Wilkinson RH. et al. Educational disabilities among children born with neonatal abstinence syndrome. Pediatrics 2018; 142 (03) e20180562
    CrossrefPubMedGoogle Scholar
  • 40 Oei JL, Melhuish E, Uebel H. et al. Neonatal abstinence syndrome and high school performance. Pediatrics 2017; 139 (02) e20162651
    CrossrefPubMedGoogle Scholar
  • 41 Meyer M, Phillips J. Caring for pregnant opioid abusers in Vermont: a potential model for non-urban areas. Prev Med 2015; 80: 18-22
    CrossrefPubMedGoogle Scholar
  • 42 Ko JYWS, Wolicki S, Barfield WD. et al. CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome. Morb Mortal Wkly Rep 2017; 66 (09) 242-245
    CrossrefPubMedGoogle Scholar
  • 43 Madras BK. The surge of opioid use, addiction, and overdoses: responsibility and response of the US Health Care System. JAMA Psychiatry 2017; 74 (05) 441-442
    CrossrefPubMedGoogle Scholar
  • 44 Koh HK. Community-based prevention and strategies for the opioid crisis. JAMA 2017; 318 (11) 993-994
    CrossrefPubMedGoogle Scholar
  • 45 Patrick SW, Schiff DM. COMMITTEE ON SUBSTANCE USE AND PREVENTION. A public health response to opioid use in pregnancy. Pediatrics 2017; 139 (03) e20164070
    CrossrefPubMedGoogle Scholar
  • 46 Grossman MR, Lipshaw MJ, Osborn RR, Berkwitt AK. A novel approach to assessing infants with neonatal abstinence syndrome. Hosp Pediatr 2018; 8 (01) 1-6
    CrossrefPubMedGoogle Scholar